Now that weve shown that hormone-based therapies can be so effective, I think its changed the worlds perspective that its not a losing battle to treat obesity. Daniel Drucker, professor of medicine at the University of Toronto, who codiscovered GLP-1 in the 1980s, says more drugs are needed because theres no telling how long the current shortage of Wegovy and Zepbound will last
In addition to laboratory-based studies, academic publications and scientific conferences have contributed to broader discussions regarding peptide-related research
others (like a tri-agonist by Pfizer) are in mid-stage trials
GLP-1 medications reduce appetite and overall food intake
Physiology, Cortisol, StatPearls, US National Library of Medicine, National Institutes of Health
Its a tough time to compete with new weight-loss drugs